{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T17:24:02Z","timestamp":1785259442389,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13256-019-2045-4","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:03:37Z","timestamp":1556064217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adult hypophosphatasia with compound heterozygous p.Phe327Leu missense and c.1559delT frameshift mutations in tissue-nonspecific alkaline phosphatase gene: a case report"],"prefix":"10.1186","volume":"13","author":[{"given":"Kazunori","family":"Fukushima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Kawai-Kowase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Yonemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahito","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Ozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junich","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"key":"2045_CR1","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/archpedi.1948.02030020840003","volume":"75","author":"JC Rathbun","year":"1948","unstructured":"Rathbun JC. Hypophosphatasia, a new developmental anomaly. Am J Dis Child. 1948;75:822\u201331.","journal-title":"Am J Dis Child"},{"key":"2045_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/B978-0-12-387829-8.00022-6","volume-title":"Genetics of bone biology and skeletal disease","author":"MP Whyte","year":"2013","unstructured":"Whyte MP. Hypophosphatasia. In: Thakker RV, Whyte MP, Eisman JA, Igarashi T, editors. Genetics of bone biology and skeletal disease. London: Academic Press; 2013. p. 337\u201360."},{"key":"2045_CR3","unstructured":"Mornet E. The tissue nonspecific alkaline phosphatase gene mutations database. \n                    http:\/\/www.sesep.uvsq.fr\/03_hypo_mutations.php\n                    \n                  . Accessed 6 Sept 2018."},{"key":"2045_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/00005792-197909000-00001","volume":"58","author":"MP Whyte","year":"1979","unstructured":"Whyte MP, Teitelbaum SL, Murphy WA, Bergfeld MA, Avioli LV. Adult hypophosphatasia: clinical, laboratory, and genetic investigation of a large kindred with review of the literature. Medicine (Baltimore). 1979;58:329\u201347.","journal-title":"Medicine (Baltimore)"},{"key":"2045_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bone.2013.01.024","volume":"54","author":"KE Berkseth","year":"2013","unstructured":"Berkseth KE, Tebben PJ, Drake MT, Hefferan TE, Jewison DE, Wermers RA. Clinical spectrum of hypophosphatasia diagnosed in adults. Bone. 2013;54:21\u20137.","journal-title":"Bone."},{"key":"2045_CR6","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.metabol.2016.07.006","volume":"65","author":"TJ Weber","year":"2016","unstructured":"Weber TJ, Sawyer EK, Moseley S, Odrljin T, Kishnani PS. Burden of disease in adult patients with hypophosphatasia: results from two patient-reported surveys. Metabolism. 2016;65:1522\u201330.","journal-title":"Metabolism."},{"key":"2045_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.11138\/ccmbm\/2017.14.1.230","volume":"14","author":"F Conti","year":"2017","unstructured":"Conti F, Ciullini L, Pugliese G. Hypophosphatasia: clinical manifestation and burden of disease in adult patients. Clin Cases Miner Bone Metab. 2017;14:230\u20134.","journal-title":"Clin Cases Miner Bone Metab"},{"key":"2045_CR8","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/jbmr.2178","volume":"29","author":"FE McKiernan","year":"2014","unstructured":"McKiernan FE, Berg RL, Fuehrer J. Clinical and radiographic findings in adults with persistent hypophosphatasemia. J Bone Miner Res. 2014;29:1651\u201360.","journal-title":"J Bone Miner Res"},{"key":"2045_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/archdischild-2013-305037","volume":"99","author":"T Taketani","year":"2014","unstructured":"Taketani T, Onigata K, Kobayashi H, Mushimoto Y, Fukuda S, Yamaguchi S. Clinical and genetic aspects of hypophosphatasia in Japanese patients. Arch Dis Child. 2014;99:211\u20135.","journal-title":"Arch Dis Child"},{"issue":"Suppl 2","key":"2045_CR10","first-page":"1","volume":"15","author":"K Rasmussen","year":"1968","unstructured":"Rasmussen K. Phosphorylethanolamine and hypophosphatasia. Dan Med Bull. 1968;15(Suppl 2):1\u2013112.","journal-title":"Dan Med Bull"},{"key":"2045_CR11","first-page":"4458","volume":"81","author":"K Ozono","year":"1996","unstructured":"Ozono K, Yamagata M, Michigami T, et al. Identification of novel missense mutations (Phe310Leu and Gly439Arg) in a neonatal case of hypophosphatasia. J Clin Endocrinol Metab. 1996;81:4458\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"2045_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00431-004-1612-9","volume":"164","author":"T Michigami","year":"2005","unstructured":"Michigami T, Uchihashi T, Suzuki A, Tachikawa K, Nakajima S, Ozono K. Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia. Eur J Pediatr. 2005;164:277\u201382.","journal-title":"Eur J Pediatr"},{"key":"2045_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/jhg.2010.161","volume":"56","author":"A Watanabe","year":"2011","unstructured":"Watanabe A, Karasugi T, Sawai H, et al. Prevalence of c.1559delT in ALPL, a common mutation resulting in the perinatal (lethal) form of hypophosphatasia in Japanese and effects of the mutation on heterozygous carriers. J Hum Genet. 2011;56:166\u20138.","journal-title":"J Hum Genet"},{"key":"2045_CR14","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1001\/archinternmed.2011.447","volume":"171","author":"ES LeBlanc","year":"2011","unstructured":"LeBlanc ES, Hillier TA, Pedula KL, et al. Hip fracture and increased short-term but not long-term mortality in healthy older women. Arch Intern Med. 2011;171:1831\u20137.","journal-title":"Arch Intern Med"},{"key":"2045_CR15","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1359\/jbmr.081253","volume":"24","author":"MP Whyte","year":"2009","unstructured":"Whyte MP. Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J Bone Miner Res. 2009;24:1132\u20134.","journal-title":"J Bone Miner Res"},{"key":"2045_CR16","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/jbmr.1565","volume":"27","author":"RA Sutton","year":"2012","unstructured":"Sutton RA, Mumm S, Coburn SP, et al. \u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res. 2012;27:987\u201394.","journal-title":"J Bone Miner Res"},{"key":"2045_CR17","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/jbmr.2495","volume":"30","author":"T Cundy","year":"2015","unstructured":"Cundy T, Michigami T, Tachikawa K, et al. Reversible deterioration in hypophosphatasia caused by renal failure with bisphosphonate treatment. J Bone Miner Res. 2015;30:1726\u201337.","journal-title":"J Bone Miner Res"},{"key":"2045_CR18","doi-asserted-by":"publisher","first-page":"941","DOI":"10.4158\/EP15890.OR","volume":"22","author":"PM Camacho","year":"2016","unstructured":"Camacho PM, Mazhari AM, Wilczynski C, Kadanoff R, Mumm W, Whyte MP. Adult hypophosphatasia treated with teriparatide: report of 2 patients and review of the literature. Endocr Pract. 2016;22:941\u201350.","journal-title":"Endocr Pract"},{"key":"2045_CR19","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1210\/jc.2006-1902","volume":"92","author":"MP Whyte","year":"2007","unstructured":"Whyte MP, Mumm S, Deal C. Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab. 2007;92:1203\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2045_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jbspin.2017.12.001","volume":"85","author":"M Righetti","year":"2018","unstructured":"Righetti M, Wach J, Desmarchelier R, Coury F. Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures. Joint Bone Spine. 2018;85:365\u20137.","journal-title":"Joint Bone Spine"},{"key":"2045_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00223-011-9562-5","volume":"90","author":"M Laroche","year":"2012","unstructured":"Laroche M. Failure of teriparatide in treatment of bone complications of adult hypophosphatasia. Calcif Tissue Int. 2012;90:250.","journal-title":"Calcif Tissue Int"},{"key":"2045_CR22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte MP, Greenberg CR, Salman NJ, et al. Enzyme replacement therapy in life-threatening hypophosphatasia. N Engl J Med. 2012;366:904\u201313.","journal-title":"N Engl J Med"},{"key":"2045_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1210\/jc.2015-3462","volume":"101","author":"MP Whyte","year":"2016","unstructured":"Whyte MP, Rockman-Greenberg C, Ozono K, et al. Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia. J Clin Endcrinol Metab. 2016;101:334\u201342.","journal-title":"J Clin Endcrinol Metab"},{"issue":"9","key":"2045_CR24","doi-asserted-by":"publisher","first-page":"e85971","DOI":"10.1172\/jci.insight.85971","volume":"1","author":"MP Whyte","year":"2016","unstructured":"Whyte MP, Madson KL, Phillips D, et al. Asfotase alfa therapy for children with hypophosphatasia. JCI Insight. 2016;1(9):e85971.","journal-title":"JCI Insight"},{"key":"2045_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/cen.13343","volume":"87","author":"T Kitaoka","year":"2017","unstructured":"Kitaoka T, Tajima T, Nagasaki K, et al. Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: results from a Japanese clinical trial. Clin Endocrinol. 2017;87:10\u20139.","journal-title":"Clin Endocrinol"},{"key":"2045_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ymgmr.2017.10.006","volume":"14","author":"G Costain","year":"2018","unstructured":"Costain G, Moore AM, Munroe L, et al. Enzyme replacement therapy in perinatal hypophosphatasia: case report of a negative outcome and lessons for clinical practice. Mol Genet Metab Rep. 2018;14:22\u20136.","journal-title":"Mol Genet Metab Rep"},{"key":"2045_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.berh.2007.11.003","volume":"22","author":"E Mornet","year":"2008","unstructured":"Mornet E. Hypophosphatasia. Best Pract Res Clin Rheumatol. 2008;22:113\u201327.","journal-title":"Best Pract Res Clin Rheumatol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2045-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-019-2045-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2045-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T23:08:48Z","timestamp":1587596928000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-019-2045-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,24]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2045"],"URL":"https:\/\/doi.org\/10.1186\/s13256-019-2045-4","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,24]]},"assertion":[{"value":"4 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki declaration.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KO has received honoraria and consultancy fees from Alexion Pharmaceuticals, Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"101"}}